Efficacy and safety of dulaglutide in patients with absolute insulin deficiency

Autor: Kutoh Eiji, Hayashi Jyunka, Kuto Alexandra N.

Publikováno v: Endocrine Regulations, Vol 53, Iss 3, Pp 187-190 (2019)

Objective. While dulaglutide has been approved inpatients with type 2 diabetes (T2DM) in combination with insulin, it has not been studied in insulin-deficient patients, not whether they have type 1 diabetes (T1DM) or T2DM. The aim of this study is t

Externí odkaz: https://doaj.org/article/b286433da4974cd4b09087741399d287

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Link between body weight changes and metabolic parameters in drugs naïve subjects with type 2 diabetes treated with canagliflozin monotherapy

Autor: Kutoh, Eiji, Wada, Asuka, Kuto, Alexandra N., Hayashi, Jyunka, Kurihara, Rumi

Publikováno v: Hospital Practice; March 2020, Vol. 48 Issue: 2 p68-74, 7p

Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes.

Autor: Kutoh E; Division of Clinical Research, Biomedical Center, Tokyo, Japan.; Department of Internal Medicine, Division of Endocrinology and Metabolism, Gyoda General Hospital, Saitama, Japan.; Department of Internal Medicine, Division of Diabetes and Metabolism, Higashitotsuka Memorial Hospital, Yokohama, Japan., Wada A; Department of Internal Medicine, Division of Endocrinology and Metabolism, Gyoda General Hospital, Saitama, Japan., Murayama T; Division of Clinical Research, Biomedical Center, Tokyo, Japan., Hayashi J; Department of Internal Medicine, Division of Endocrinology and Metabolism, Gyoda General Hospital, Saitama, Japan.

Publikováno v: Indian journal of endocrinology and metabolism [Indian J Endocrinol Metab] 2018 Mar-Apr; Vol. 22 (2), pp. 185-190.